FDA Issues New Breast Implant Guidance While Giving Another A Nip And Tuck
Executive Summary
The US FDA gives recommendations on the labeling of breast implants in a 29 September final guidance doc. The agency also revised a separate breast implant guidance last updated in 2006 to include, among other things, information found in the new labeling guidance.
You may also be interested in...
FDA Strengthens Safety Requirements For Breast Implants
The US FDA has approved new labeling for all legally marketed breast implants that includes a boxed warning of potential risks. The agency also released updated information on the status of implant manufacturer post-approval studies.
New Material Safety Reports Highlight Lack Of Data To Fully Evaluate Adverse Reactions
The US FDA and ECRI released four reports about the safety of certain materials used in medical devices. While the risks seem to be comparatively low, they note the quality of literature is lacking to make broad evaluations.
FDA Calls For More Warnings On Breast Implant Labeling
Suggested revisions to breast implant labeling guidance from the US FDA include a boxed warning, patient decision checklist, and additional information for patients about device ingredients. The changes follow growing concerns over the safety of certain implants.